Know Cancer

or
forgot password

Pilot Study of 18F-FLT Pet Imaging in Cancer Patients


N/A
18 Years
N/A
Not Enrolling
Female
CNS Brain Metastasis, Head and Neck Cancer, Lung Cancer, Prostate Cancer, Esophageal Cancer

Thank you

Trial Information

Pilot Study of 18F-FLT Pet Imaging in Cancer Patients


Inclusion Criteria:



- Able to tolerate a PET/CT scan

- Age of 18 or older

- signed informed consent

- being considered for radiotherapy for treatment of CNS mets, Head and neck cancer,
lung cancer, prostate cancer or esophageal cancer

Exclusion Criteria:

- Prior XRT to site being studied

- severe claustrophobia or inability to tolerate PET/CT

- unable to provide written consent

- pregnant or breastfeeding women

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To test whether the cellular response to fractionated radiotherapy leads to observable global change in the uptake of 18F-FLT as assessed by PET imaging

Outcome Time Frame:

end of study

Safety Issue:

No

Principal Investigator

Robert Jeraj, Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Wisconsin, Madison

Authority:

United States: Food and Drug Administration

Study ID:

HSC-2006-0280

NCT ID:

NCT00585741

Start Date:

December 2006

Completion Date:

December 2011

Related Keywords:

  • CNS Brain Metastasis
  • Head and Neck Cancer
  • Lung Cancer
  • Prostate Cancer
  • Esophageal Cancer
  • Esophageal Diseases
  • Esophageal Neoplasms
  • Head and Neck Neoplasms
  • Lung Neoplasms
  • Neoplasm Metastasis
  • Prostatic Neoplasms
  • Brain Neoplasms

Name

Location

University of Wisconsin Hospital and clinisMadison, Wisconsin  53792